About
Oral Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalNon-PharmaceuticalMiddle East
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
318
By Phase
PHASE1/PHASE2: 1PHASE2: 3PHASE1: 2
By Status
COMPLETED: 5ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05965167Lead Sponsor
Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo
PHASE1/PHASE2Active, not recruiting
45 participants
Started: May 11, 2023 · Completed: May 31, 2026
NCT04003467Lead Sponsor
A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass
PHASE2Completed
161 participants
Started: Jun 30, 2019 · Completed: May 11, 2021
NCT03516773Lead Sponsor
Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism
PHASE2Completed
20 participants
Started: Jun 17, 2018 · Completed: Feb 24, 2019
NCT02152228Lead Sponsor
A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
PHASE2Completed
20 participants
Started: Jul 31, 2014 · Completed: Jul 31, 2015
NCT02571140Lead Sponsor
A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects
PHASE1Completed
30 participants
Started: Oct 31, 2013 · Completed: Oct 31, 2017
Locations (1)
Headquarters
Jerusalem, Israel
Map
Loading map...